Loading company…
Vaporox develops hyperoxia therapy technology for wound treatment.
Vaporox develops Vaporous Hyperoxia Therapy (VHT-100), a treatment for diabetic foot ulcers and other wounds. The system uses ultrasonic waves to create water and antimicrobial particles that are delivered with oxygen-enriched air to the treatment site. Founded in 2016, the company is based in Colorado, US, and was founded by Alan Sage. In June 2021, it raised USD 4.9 million in venture funding from Bioventus LLC.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in